List of Tables
Table 1. Global Pulmonary Drug Delivery Systems Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Pulmonary Drug Delivery Systems Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Pulmonary Drug Delivery Systems Market Competitive Situation by Manufacturers in 2025
Table 4. Global Pulmonary Drug Delivery Systems Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Pulmonary Drug Delivery Systems Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Pulmonary Drug Delivery Systems Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Pulmonary Drug Delivery Systems Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Pulmonary Drug Delivery Systems Average Price (USD/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Pulmonary Drug Delivery Systems, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Pulmonary Drug Delivery Systems, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Pulmonary Drug Delivery Systems, Product Types and Applications
Table 12. Global Key Manufacturers of Pulmonary Drug Delivery Systems, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Pulmonary Drug Delivery Systems Companies by Tier (Tier 1, Tier 2, Tier 3), based on Pulmonary Drug Delivery Systems Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Pulmonary Drug Delivery Systems Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Pulmonary Drug Delivery Systems Sales by Region (K Units), 2021–2026
Table 18. Global Pulmonary Drug Delivery Systems Sales Market Share by Region (2021–2026)
Table 19. Global Pulmonary Drug Delivery Systems Sales by Region (K Units), 2027–2032
Table 20. Global Pulmonary Drug Delivery Systems Sales Market Share by Region (2027–2032)
Table 21. Global Pulmonary Drug Delivery Systems Revenue by Region (US$ Million), 2021–2026
Table 22. Global Pulmonary Drug Delivery Systems Revenue Market Share by Region (2021–2026)
Table 23. Global Pulmonary Drug Delivery Systems Revenue by Region (US$ Million), 2027–2032
Table 24. Global Pulmonary Drug Delivery Systems Revenue Market Share by Region (2027–2032)
Table 25. North America Pulmonary Drug Delivery Systems Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Pulmonary Drug Delivery Systems Sales by Country (K Units), 2021–2026
Table 27. North America Pulmonary Drug Delivery Systems Sales by Country (K Units), 2027–2032
Table 28. North America Pulmonary Drug Delivery Systems Revenue by Country (US$ Million), 2021–2026
Table 29. North America Pulmonary Drug Delivery Systems Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Pulmonary Drug Delivery Systems Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Pulmonary Drug Delivery Systems Sales by Country (K Units), 2021–2026
Table 32. Europe Pulmonary Drug Delivery Systems Sales by Country (K Units), 2027–2032
Table 33. Europe Pulmonary Drug Delivery Systems Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Pulmonary Drug Delivery Systems Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Pulmonary Drug Delivery Systems Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Pulmonary Drug Delivery Systems Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Pulmonary Drug Delivery Systems Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Pulmonary Drug Delivery Systems Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Pulmonary Drug Delivery Systems Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Pulmonary Drug Delivery Systems Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Pulmonary Drug Delivery Systems Sales by Country (K Units), 2021–2026
Table 42. Latin America Pulmonary Drug Delivery Systems Sales by Country (K Units), 2027–2032
Table 43. Latin America Pulmonary Drug Delivery Systems Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Pulmonary Drug Delivery Systems Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Pulmonary Drug Delivery Systems Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Pulmonary Drug Delivery Systems Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Pulmonary Drug Delivery Systems Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Pulmonary Drug Delivery Systems Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Pulmonary Drug Delivery Systems Revenue by Country (US$ Million), 2027–2032
Table 50. Global Pulmonary Drug Delivery Systems Sales (K Units) by Type (2021–2026)
Table 51. Global Pulmonary Drug Delivery Systems Sales (K Units) by Type (2027–2032)
Table 52. Global Pulmonary Drug Delivery Systems Sales Market Share by Type (2021–2026)
Table 53. Global Pulmonary Drug Delivery Systems Sales Market Share by Type (2027–2032)
Table 54. Global Pulmonary Drug Delivery Systems Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Pulmonary Drug Delivery Systems Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Pulmonary Drug Delivery Systems Revenue Market Share by Type (2021–2026)
Table 57. Global Pulmonary Drug Delivery Systems Revenue Market Share by Type (2027–2032)
Table 58. Global Pulmonary Drug Delivery Systems Price (USD/Unit) by Type (2021–2026)
Table 59. Global Pulmonary Drug Delivery Systems Price (USD/Unit) by Type (2027–2032)
Table 60. Global Pulmonary Drug Delivery Systems Sales (K Units) by Application (2021–2026)
Table 61. Global Pulmonary Drug Delivery Systems Sales (K Units) by Application (2027–2032)
Table 62. Global Pulmonary Drug Delivery Systems Sales Market Share by Application (2021–2026)
Table 63. Global Pulmonary Drug Delivery Systems Sales Market Share by Application (2027–2032)
Table 64. Global Pulmonary Drug Delivery Systems Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Pulmonary Drug Delivery Systems Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Pulmonary Drug Delivery Systems Revenue Market Share by Application (2021–2026)
Table 67. Global Pulmonary Drug Delivery Systems Revenue Market Share by Application (2027–2032)
Table 68. Global Pulmonary Drug Delivery Systems Price (USD/Unit) by Application (2021–2026)
Table 69. Global Pulmonary Drug Delivery Systems Price (USD/Unit) by Application (2027–2032)
Table 70. 3M Company Information
Table 71. 3M Description and Business Overview
Table 72. 3M Pulmonary Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 73. 3M Pulmonary Drug Delivery Systems Product
Table 74. 3M Recent Developments/Updates
Table 75. GSK Company Information
Table 76. GSK Description and Business Overview
Table 77. GSK Pulmonary Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 78. GSK Pulmonary Drug Delivery Systems Product
Table 79. GSK Recent Developments/Updates
Table 80. AstraZeneca Company Information
Table 81. AstraZeneca Description and Business Overview
Table 82. AstraZeneca Pulmonary Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 83. AstraZeneca Pulmonary Drug Delivery Systems Product
Table 84. AstraZeneca Recent Developments/Updates
Table 85. Cipla Company Information
Table 86. Cipla Description and Business Overview
Table 87. Cipla Pulmonary Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 88. Cipla Pulmonary Drug Delivery Systems Product
Table 89. Cipla Recent Developments/Updates
Table 90. Chiesi Company Information
Table 91. Chiesi Description and Business Overview
Table 92. Chiesi Pulmonary Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 93. Chiesi Pulmonary Drug Delivery Systems Product
Table 94. Chiesi Recent Developments/Updates
Table 95. Boehringer Ingelheim Company Information
Table 96. Boehringer Ingelheim Description and Business Overview
Table 97. Boehringer Ingelheim Pulmonary Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 98. Boehringer Ingelheim Pulmonary Drug Delivery Systems Product
Table 99. Boehringer Ingelheim Recent Developments/Updates
Table 100. Aptar Company Information
Table 101. Aptar Description and Business Overview
Table 102. Aptar Pulmonary Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 103. Aptar Pulmonary Drug Delivery Systems Product
Table 104. Aptar Recent Developments/Updates
Table 105. Novartis Company Information
Table 106. Novartis Description and Business Overview
Table 107. Novartis Pulmonary Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 108. Novartis Pulmonary Drug Delivery Systems Product
Table 109. Novartis Recent Developments/Updates
Table 110. Philips Respironics Company Information
Table 111. Philips Respironics Description and Business Overview
Table 112. Philips Respironics Pulmonary Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 113. Philips Respironics Pulmonary Drug Delivery Systems Product
Table 114. Philips Respironics Recent Developments/Updates
Table 115. Omron Healthcare Company Information
Table 116. Omron Healthcare Description and Business Overview
Table 117. Omron Healthcare Pulmonary Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 118. Omron Healthcare Pulmonary Drug Delivery Systems Product
Table 119. Omron Healthcare Recent Developments/Updates
Table 120. PARI Company Information
Table 121. PARI Description and Business Overview
Table 122. PARI Pulmonary Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 123. PARI Pulmonary Drug Delivery Systems Product
Table 124. PARI Recent Developments/Updates
Table 125. Skyepharma Company Information
Table 126. Skyepharma Description and Business Overview
Table 127. Skyepharma Pulmonary Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 128. Skyepharma Pulmonary Drug Delivery Systems Product
Table 129. Skyepharma Recent Developments/Updates
Table 130. CareFusion Company Information
Table 131. CareFusion Description and Business Overview
Table 132. CareFusion Pulmonary Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 133. CareFusion Pulmonary Drug Delivery Systems Product
Table 134. CareFusion Recent Developments/Updates
Table 135. Shanghai Huarui Company Information
Table 136. Shanghai Huarui Description and Business Overview
Table 137. Shanghai Huarui Pulmonary Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 138. Shanghai Huarui Pulmonary Drug Delivery Systems Product
Table 139. Shanghai Huarui Recent Developments/Updates
Table 140. Taian Character Company Information
Table 141. Taian Character Description and Business Overview
Table 142. Taian Character Pulmonary Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 143. Taian Character Pulmonary Drug Delivery Systems Product
Table 144. Taian Character Recent Developments/Updates
Table 145. Chia Tai Tianqing Company Information
Table 146. Chia Tai Tianqing Description and Business Overview
Table 147. Chia Tai Tianqing Pulmonary Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 148. Chia Tai Tianqing Pulmonary Drug Delivery Systems Product
Table 149. Chia Tai Tianqing Recent Developments/Updates
Table 150. Key Raw Materials Lists
Table 151. Raw Materials Key Suppliers Lists
Table 152. Pulmonary Drug Delivery Systems Distributors List
Table 153. Pulmonary Drug Delivery Systems Customers List
Table 154. Pulmonary Drug Delivery Systems Market Trends
Table 155. Pulmonary Drug Delivery Systems Market Drivers
Table 156. Pulmonary Drug Delivery Systems Market Challenges
Table 157. Pulmonary Drug Delivery Systems Market Restraints
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
Table 161. Authors List of This Report
List of Figures
Figure 1. Product Picture of Pulmonary Drug Delivery Systems
Figure 2. Global Pulmonary Drug Delivery Systems Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Pulmonary Drug Delivery Systems Market Share by Type: 2025 & 2032
Figure 4. Nebulizers Product Picture
Figure 5. Dry Powder Inhaler (DPI) Product Picture
Figure 6. Metered Dose Inhaler (MDI) Product Picture
Figure 7. Global Pulmonary Drug Delivery Systems Market Value by Application (US$ Million), 2021–2032
Figure 8. Global Pulmonary Drug Delivery Systems Market Share by Application: 2025 & 2032
Figure 9. COPD
Figure 10. Asthma
Figure 11. Others
Figure 12. Global Pulmonary Drug Delivery Systems Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 13. Global Pulmonary Drug Delivery Systems Market Size (US$ Million), 2021–2032
Figure 14. Global Pulmonary Drug Delivery Systems Sales (K Units), 2021–2032
Figure 15. Global Pulmonary Drug Delivery Systems Average Price (USD/Unit), 2021–2032
Figure 16. Pulmonary Drug Delivery Systems Report Years Considered
Figure 17. Pulmonary Drug Delivery Systems Sales Share by Manufacturers in 2025
Figure 18. Global Pulmonary Drug Delivery Systems Revenue Share by Manufacturers in 2025
Figure 19. Top 5 and Top 10 Global Pulmonary Drug Delivery Systems Players: Market Share by Revenue in Pulmonary Drug Delivery Systems in 2025
Figure 20. Pulmonary Drug Delivery Systems Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 21. Global Pulmonary Drug Delivery Systems Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 22. North America Pulmonary Drug Delivery Systems Sales Market Share by Country (2021–2032)
Figure 23. North America Pulmonary Drug Delivery Systems Revenue Market Share by Country (2021–2032)
Figure 24. U.S. Pulmonary Drug Delivery Systems Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Canada Pulmonary Drug Delivery Systems Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Europe Pulmonary Drug Delivery Systems Sales Market Share by Country (2021–2032)
Figure 27. Europe Pulmonary Drug Delivery Systems Revenue Market Share by Country (2021–2032)
Figure 28. Germany Pulmonary Drug Delivery Systems Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. France Pulmonary Drug Delivery Systems Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. U.K. Pulmonary Drug Delivery Systems Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Italy Pulmonary Drug Delivery Systems Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Russia Pulmonary Drug Delivery Systems Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Asia Pacific Pulmonary Drug Delivery Systems Sales Market Share by Region (2021–2032)
Figure 34. Asia Pacific Pulmonary Drug Delivery Systems Revenue Market Share by Region (2021–2032)
Figure 35. China Pulmonary Drug Delivery Systems Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. Japan Pulmonary Drug Delivery Systems Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. South Korea Pulmonary Drug Delivery Systems Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. India Pulmonary Drug Delivery Systems Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Australia Pulmonary Drug Delivery Systems Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. China Taiwan Pulmonary Drug Delivery Systems Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Indonesia Pulmonary Drug Delivery Systems Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Thailand Pulmonary Drug Delivery Systems Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Malaysia Pulmonary Drug Delivery Systems Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Latin America Pulmonary Drug Delivery Systems Sales Market Share by Country (2021–2032)
Figure 45. Latin America Pulmonary Drug Delivery Systems Revenue Market Share by Country (2021–2032)
Figure 46. Mexico Pulmonary Drug Delivery Systems Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Brazil Pulmonary Drug Delivery Systems Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Argentina Pulmonary Drug Delivery Systems Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Middle East and Africa Pulmonary Drug Delivery Systems Sales Market Share by Country (2021–2032)
Figure 50. Middle East and Africa Pulmonary Drug Delivery Systems Revenue Market Share by Country (2021–2032)
Figure 51. Turkey Pulmonary Drug Delivery Systems Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Saudi Arabia Pulmonary Drug Delivery Systems Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. UAE Pulmonary Drug Delivery Systems Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. Global Sales Market Share of Pulmonary Drug Delivery Systems by Type (2021–2032)
Figure 55. Global Revenue Market Share of Pulmonary Drug Delivery Systems by Type (2021–2032)
Figure 56. Global Pulmonary Drug Delivery Systems Price (USD/Unit) by Type (2021–2032)
Figure 57. Global Sales Market Share of Pulmonary Drug Delivery Systems by Application (2021–2032)
Figure 58. Global Revenue Market Share of Pulmonary Drug Delivery Systems by Application (2021–2032)
Figure 59. Global Pulmonary Drug Delivery Systems Price (USD/Unit) by Application (2021–2032)
Figure 60. Pulmonary Drug Delivery Systems Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
